DIABETE TYPE 2

This early study tests if injecting a person's own fat stem cells into the upper gut can safely improve blood sugar control in type 2 diabetes. The approach aims to reduce inflammation and help the body respond better to insulin. Fifteen adults with diabetes will be enrolled to c…

This study compares two diabetes drugs, empagliflozin and glimepiride, added to standard treatment in 200 adults with type 2 diabetes. The goal is to see which combination better controls blood sugar without causing low blood sugar or weight gain. Participants must be over 19 and…

This study tests whether a daily probiotic called LP-LDL® can improve cholesterol, blood sugar, inflammation, and memory in 210 adults with prediabetes, type 1, or type 2 diabetes who also have high cholesterol or triglycerides. Participants take either the probiotic or a placebo…

This study tests whether a drug called Henggliejin can improve fatty liver in people who have both type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). About 149 adults will take the drug for 48 weeks, and doctors will check liver health using a simple blood test called …

This study tests a new way of managing care for older adults (ages 60-74) who have both high blood pressure and type 2 diabetes. About 960 people from rural community health centers will either receive the new integrated care package or continue with standard care. The goal is to…

This study tests a new long-acting version of semaglutide (a diabetes drug) that is given once a month instead of weekly. It aims to see if it is safe and works well for adults with type 2 diabetes. About 24 people will take part, and researchers will check side effects, blood su…

This study looks at whether eating 3 dates each day for 8 weeks can improve blood sugar control and reduce oxidative stress in people with well-controlled type 2 diabetes. Researchers will replace a carbohydrate portion in the diet with dates to see if it helps without raising bl…

This study will test three approaches to help people aged 35-85 with moderate to severe diabetic nerve pain in their legs. The approaches are a special therapy called Intraneural Facilitation (INF), a diet that removes certain foods, or both together. The goal is to see which met…

This early-stage study tests whether a new tablet that combines two common medicines (for diabetes and high blood pressure) works the same in the body as taking the two drugs separately. It involves 36 healthy Caucasian adults who will receive each treatment once, with a week bre…

This early-stage study tests a single injection of a new drug called efsubaglutide alfa (YN-011) in 48 healthy adults in Brazil. The goal is to check safety, how the body processes the drug, and its effects, not to treat diabetes. Participants receive either a low dose, a higher …

This study monitors heart rate variability in 150 adults with type 2 diabetes who also have heart failure, chronic kidney disease, or both. Participants will wear a 24-hour heart monitor before and after starting a standard SGLT2 inhibitor medication. The goal is to understand ho…